My Quote Request
No products added yet
6505-01-301-2669
20 Products
TOTACILLIN-N ADD-VANTAGE
AMPICILLIN SODIUM,USP
NSN, MFG P/N
6505013012669
NSN
6505-01-301-2669
TOTACILLIN-N ADD-VANTAGE
AMPICILLIN SODIUM,USP
NSN, MFG P/N
6505013012669
NSN
6505-01-301-2669
MFG
KING PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS AMPICILLIN EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMPICILLIN SODIUM STERILE USP POWDER FORM 2GM VIAL 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: IN A 15 ML CAPACITY GLASS VIAL W/DOUBLED LEAD SCREW THREAD TO INTERLOCK W/INLET PORT OF DEXTROSE INJECTION,6505-01-260-1237,6505-01-260-1238,6505-01-260-1239 AND SODIUM CHLORIDE INJECTION,6505-01-260-1241,6505-01-250-1242 AND 6505-01-260-6715; EACH VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
~1: ENCLOSED IN AN UPPER AND LOWER SHROUD
Related Searches:
TOTACILLIN-N
AMPICILLIN SODIUM,USP
NSN, MFG P/N
6505013012669
NSN
6505-01-301-2669
MFG
KING PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS AMPICILLIN EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMPICILLIN SODIUM STERILE USP POWDER FORM 2GM VIAL 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: IN A 15 ML CAPACITY GLASS VIAL W/DOUBLED LEAD SCREW THREAD TO INTERLOCK W/INLET PORT OF DEXTROSE INJECTION,6505-01-260-1237,6505-01-260-1238,6505-01-260-1239 AND SODIUM CHLORIDE INJECTION,6505-01-260-1241,6505-01-250-1242 AND 6505-01-260-6715; EACH VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
~1: ENCLOSED IN AN UPPER AND LOWER SHROUD
Related Searches:
F91G206
CLINDAMYCIN INJECTION,USP
NSN, MFG P/N
6505013013789
NSN
6505-01-301-3789
MFG
AIR FORCE MEDICAL LOGISTICS OFFICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS CLINDAMYCIN EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR AND INTRAVENOUS
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ABBOTT LAB
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00009-0775-20
CLINDAMYCIN INJECTION,USP
NSN, MFG P/N
6505013013789
NSN
6505-01-301-3789
NDC00009-0775-20
CLINDAMYCIN INJECTION,USP
NSN, MFG P/N
6505013013789
NSN
6505-01-301-3789
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS CLINDAMYCIN EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR AND INTRAVENOUS
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ABBOTT LAB
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00074-4054-03
CLINDAMYCIN INJECTION,USP
NSN, MFG P/N
6505013013789
NSN
6505-01-301-3789
NDC00074-4054-03
CLINDAMYCIN INJECTION,USP
NSN, MFG P/N
6505013013789
NSN
6505-01-301-3789
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS CLINDAMYCIN EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR AND INTRAVENOUS
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ABBOTT LAB
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00469-2820-70
CLINDAMYCIN INJECTION,USP
NSN, MFG P/N
6505013013789
NSN
6505-01-301-3789
NDC00469-2820-70
CLINDAMYCIN INJECTION,USP
NSN, MFG P/N
6505013013789
NSN
6505-01-301-3789
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS CLINDAMYCIN EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR AND INTRAVENOUS
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ABBOTT LAB
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00703-9110-04
CLINDAMYCIN INJECTION,USP
NSN, MFG P/N
6505013013789
NSN
6505-01-301-3789
NDC00703-9110-04
CLINDAMYCIN INJECTION,USP
NSN, MFG P/N
6505013013789
NSN
6505-01-301-3789
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS CLINDAMYCIN EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR AND INTRAVENOUS
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ABBOTT LAB
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00536-3828-10
FERROUS SULFATE TABLETS,USP
NSN, MFG P/N
6505013015352
NSN
6505-01-301-5352
NDC00536-3828-10
FERROUS SULFATE TABLETS,USP
NSN, MFG P/N
6505013015352
NSN
6505-01-301-5352
MFG
RUGBY GROUP INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 325.000 MILLIGRAMS FERROUS SULFATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00006-0207-31
LISINOPRIL TABLETS
NSN, MFG P/N
6505013015353
NSN
6505-01-301-5353
MFG
MERCK SHARP AND DOHME
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: LISINOPRIL 20 MILLIGRAMS ACTIVE INGREDIENTS
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 1
UNIT PACKAGE TYPE: PACKAGE
Related Searches:
PRINIVIL
LISINOPRIL TABLETS
NSN, MFG P/N
6505013015353
NSN
6505-01-301-5353
MFG
MERCK SHARP AND DOHME
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: LISINOPRIL 20 MILLIGRAMS ACTIVE INGREDIENTS
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 1
UNIT PACKAGE TYPE: PACKAGE
Related Searches:
NDC00026-0646-25
GLOBULIN,IMMUNE IN MALTOSE INJECTION
NSN, MFG P/N
6505013018166
NSN
6505-01-301-8166
NDC00026-0646-25
GLOBULIN,IMMUNE IN MALTOSE INJECTION
NSN, MFG P/N
6505013018166
NSN
6505-01-301-8166
MFG
TALECRIS BIOTHERAPEUTICS INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GLOBULIN IMMUNE IN MALTOSE INJECTION WITH HANGING DEVICE 250ML
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C AND SUBJECT TO DAMAGE BY FREEZING
III UNIT OF ISSUE CUBE: 0.1563 CUBIC FEET
IMMEDIATE CONTAINER TYPE: VIAL
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 250.0ML
SPECIAL FEATURES: 5 PCT GLOBULIN IN 10 PCT MALTOSE; 50MG OF IMMUNE GLOBULIN PER ML; VIAL W/HANGING DEVICE; PACKAGED TOGETHER W/INTRAVENOUS ADMINISTRATION SET
Related Searches:
NDC00161-0640-25
GLOBULIN,IMMUNE IN MALTOSE INJECTION
NSN, MFG P/N
6505013018166
NSN
6505-01-301-8166
NDC00161-0640-25
GLOBULIN,IMMUNE IN MALTOSE INJECTION
NSN, MFG P/N
6505013018166
NSN
6505-01-301-8166
MFG
CUTTER LABORATORIES INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GLOBULIN IMMUNE IN MALTOSE INJECTION WITH HANGING DEVICE 250ML
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C AND SUBJECT TO DAMAGE BY FREEZING
III UNIT OF ISSUE CUBE: 0.1563 CUBIC FEET
IMMEDIATE CONTAINER TYPE: VIAL
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 250.0ML
SPECIAL FEATURES: 5 PCT GLOBULIN IN 10 PCT MALTOSE; 50MG OF IMMUNE GLOBULIN PER ML; VIAL W/HANGING DEVICE; PACKAGED TOGETHER W/INTRAVENOUS ADMINISTRATION SET
Related Searches:
NDC00517-2602-25
MAGNESIUM SULFATE INJECTION,USP
NSN, MFG P/N
6505013018175
NSN
6505-01-301-8175
NDC00517-2602-25
MAGNESIUM SULFATE INJECTION,USP
NSN, MFG P/N
6505013018175
NSN
6505-01-301-8175
MFG
LUITPOLD PHARMACEUTICALS INC OSTEOHEALTH COMPANY OSTEOHEALTH DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 GRAMS MANGANESE SULFATE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MAGNESIUM SULFATE INJECTION USP 2ML AMPUL 25S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL OR VIAL
SPECIAL FEATURES: 4.06 MILLIEQUIVALENTS MAGNESIUM PER ML
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00002-7072-6
CEFAMANDOLE NAFATE FOR INJECTION,USP
NSN, MFG P/N
6505013018195
NSN
6505-01-301-8195
NDC00002-7072-6
CEFAMANDOLE NAFATE FOR INJECTION,USP
NSN, MFG P/N
6505013018195
NSN
6505-01-301-8195
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: EQUIVALENT TO 10 GRAMS OF CEFAMADOLE
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 100 ML. VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC00264-7800-10
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505013018197
NSN
6505-01-301-8197
NDC00264-7800-10
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505013018197
NSN
6505-01-301-8197
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
H-378
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505013018198
NSN
6505-01-301-8198
H-378
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505013018198
NSN
6505-01-301-8198
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 66.000 PERCENTAGE, W/V DIATRIZOATE MEGLUMINE ACTIVE INGREDIENT AND 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 150.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: RADIOPAQUE MEDIUM
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00024-0778-03
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505013018198
NSN
6505-01-301-8198
NDC00024-0778-03
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505013018198
NSN
6505-01-301-8198
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 66.000 PERCENTAGE, W/V DIATRIZOATE MEGLUMINE ACTIVE INGREDIENT AND 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 150.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: RADIOPAQUE MEDIUM
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
A89D099
METHOTREXATE SODIUM FOR INJECTION,USP
NSN, MFG P/N
6505013018867
NSN
6505-01-301-8867
A89D099
METHOTREXATE SODIUM FOR INJECTION,USP
NSN, MFG P/N
6505013018867
NSN
6505-01-301-8867
MFG
DEPARTMENT OF THE ARMY U S ARMY MEDICAL MATERIAL AGENCY MCMR-MMT-D
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS METHOTREXATE EQUIVALENT
ADMINISTRATION: INTRATHECAL OR PARENTERAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHOTREXATE SODIUM FOR INJECTION 1GM SINGLE DOSE VIAL
III PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
Related Searches:
NDC63323-0122-50
METHOTREXATE SODIUM FOR INJECTION,USP
NSN, MFG P/N
6505013018867
NSN
6505-01-301-8867
NDC63323-0122-50
METHOTREXATE SODIUM FOR INJECTION,USP
NSN, MFG P/N
6505013018867
NSN
6505-01-301-8867
MFG
AMERICAN PHARMACEUTICAL PARTNERS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS METHOTREXATE EQUIVALENT
ADMINISTRATION: INTRATHECAL OR PARENTERAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHOTREXATE SODIUM FOR INJECTION 1GM SINGLE DOSE VIAL
III PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
Related Searches:
ACTIDOSE
CHARCOAL,ACTIVATED,SUSPENSION
NSN, MFG P/N
6505013018870
NSN
6505-01-301-8870
ACTIDOSE
CHARCOAL,ACTIVATED,SUSPENSION
NSN, MFG P/N
6505013018870
NSN
6505-01-301-8870
MFG
PADDOCK LABORATORIES INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 208.000 MILLIGRAMS CHARCOAL, ACTIVATED PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHARCOAL ACTIVATED SUSPENSION 120ML OR 4FL OZ BOTTLE
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,PADDOCK LABS
PRIMARY CONTAINER CONTENT QUANTITY: 120.000 MILLILITERS OR 4.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: FOR DRUG OVERDOSE OR POISONING
